Published in J Cardiovasc Electrophysiol on May 01, 2003
Simultaneous epicardial and endocardial substrate mapping and radiofrequency catheter ablation as first-line treatment for ventricular tachycardia and frequent ICD shocks in chronic chagasic cardiomyopathy. J Interv Card Electrophysiol (2009) 0.82
Effects of different LAD-blocked sites on the development of acute myocardial infarction and malignant arrhythmia in a swine model. J Thorac Dis (2014) 0.79
Ventricular tachycardia in ischemic heart disease substrates. Indian Heart J (2014) 0.77
New Imaging Technologies To Characterize Arrhythmic Substrate. J Atr Fibrillation (2014) 0.75
Substrate mapping: the historical perspective and current status. J Cardiovasc Electrophysiol (2003) 0.75
Evaluation of the use of unipolar voltage amplitudes for detection of myocardial scar assessed by cardiac magnetic resonance imaging in heart failure patients. PLoS One (2017) 0.75
Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol (2013) 5.67
Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med (2007) 5.05
Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol (2013) 4.07
Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med (2013) 3.76
A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol (2008) 3.58
Prospective study of sudden cardiac death among women in the United States. Circulation (2003) 3.45
Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. J Am Coll Cardiol (2012) 3.36
Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator. Heart Rhythm (2007) 3.23
Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience. Radiology (2007) 2.93
Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol (2007) 2.90
Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study. J Am Coll Cardiol (2007) 2.79
Multi-sensor esophageal temperature probe used during radiofrequency ablation for atrial fibrillation is associated with increased intraluminal temperature detection and increased risk of esophageal injury compared to single-sensor probe. J Cardiovasc Electrophysiol (2013) 2.65
Familial aggregation in lone atrial fibrillation. Hum Genet (2005) 2.55
Importance of catheter contact force during irrigated radiofrequency ablation: evaluation in a porcine ex vivo model using a force-sensing catheter. J Cardiovasc Electrophysiol (2010) 2.47
Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension. JACC Cardiovasc Interv (2012) 2.45
Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation (2003) 2.42
Use of the electrocardiogram in acute myocardial infarction. N Engl J Med (2003) 2.40
Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study. Circ Arrhythm Electrophysiol (2013) 2.34
Recurrence of atrial fibrillation correlates with the extent of post-procedural late gadolinium enhancement: a pilot study. JACC Cardiovasc Imaging (2009) 2.33
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08
Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur Heart J (2009) 2.06
Drug-induced torsades de pointes and implications for drug development. J Cardiovasc Electrophysiol (2004) 2.05
Atrial fibrillation ablation using a robotic catheter remote control system: initial human experience and long-term follow-up results. J Am Coll Cardiol (2008) 2.02
A novel radiofrequency ablation catheter using contact force sensing: Toccata study. Heart Rhythm (2011) 1.95
National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med (2004) 1.92
The durability of pulmonary vein isolation using the visually guided laser balloon catheter: multicenter results of pulmonary vein remapping studies. Heart Rhythm (2012) 1.89
Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy. Heart Rhythm (2006) 1.87
Acute electrical isolation is a necessary but insufficient endpoint for achieving durable PV isolation: the importance of closing the visual gap. Europace (2012) 1.79
Is there a role for maintaining sinus rhythm in patients with atrial fibrillation? Ann Intern Med (2004) 1.78
Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol (2005) 1.78
QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators. J Am Coll Cardiol (2005) 1.76
Towards regenerative therapy for cardiac disease. Lancet (2012) 1.75
Esophageal injury and temperature monitoring during atrial fibrillation ablation. Circ Arrhythm Electrophysiol (2008) 1.75
Analysis of the left atrial appendage by magnetic resonance angiography in patients with atrial fibrillation. Heart Rhythm (2006) 1.75
Non-inducibility post-pulmonary vein isolation achieving exit block predicts freedom from atrial fibrillation. Eur Heart J (2005) 1.74
Effects of ventricular premature stimulus coupling interval on blood pressure and heart rate turbulence. Circulation (2002) 1.73
Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol (2006) 1.68
Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review. Arch Intern Med (2008) 1.68
Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes. Heart Rhythm (2010) 1.66
Influence of clinical and procedural predictors on ventricular tachycardia ablation outcomes: an analysis from the substrate mapping and ablation in Sinus Rhythm to Halt Ventricular Tachycardia Trial (SMASH-VT). J Cardiovasc Electrophysiol (2010) 1.65
Role of implantable cardioverter-defibrillators in patients with methadone-induced long QT syndrome. Am J Cardiol (2008) 1.63
Intracardiac echocardiographic imaging of the left atrial appendage. Heart Rhythm (2005) 1.63
The permanency of pulmonary vein isolation using a balloon cryoablation catheter. J Cardiovasc Electrophysiol (2010) 1.62
Use of intracardiac echocardiography to guide implantation of a left atrial appendage occlusion device (PLAATO). Heart Rhythm (2007) 1.61
Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial. Circ Arrhythm Electrophysiol (2014) 1.59
Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial. Circulation (2002) 1.58
Ability of terminal QRS notching to distinguish benign from malignant electrocardiographic forms of early repolarization. Am J Cardiol (2009) 1.57
Loss of pace capture on the ablation line: a new marker for complete radiofrequency lesions to achieve pulmonary vein isolation. Heart Rhythm (2009) 1.56
Crescendo in depolarization and repolarization heterogeneity heralds development of ventricular tachycardia in hospitalized patients with decompensated heart failure. Circ Arrhythm Electrophysiol (2011) 1.56
Direct comparison of percutaneous circulatory support systems in specific hemodynamic conditions in a porcine model. Circ Arrhythm Electrophysiol (2012) 1.56
Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies. Arch Intern Med (2004) 1.55
Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol (2009) 1.54
T-vector direction differentiates postpacing from ischemic T-wave inversion in precordial leads. Circulation (2005) 1.54
Integration of cardiac CT/MR imaging with three-dimensional electroanatomical mapping to guide catheter manipulation in the left atrium: implications for catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2006) 1.54
Inpatient vs. elective outpatient cardiac resynchronization therapy device implantation and long-term clinical outcome. Europace (2010) 1.53
Integration of cardiac magnetic resonance imaging with three-dimensional electroanatomic mapping to guide left ventricular catheter manipulation: feasibility in a porcine model of healed myocardial infarction. J Am Coll Cardiol (2004) 1.53
Timing of delayed perforation with the St. Jude Riata lead: a single-center experience and a review of the literature. Heart Rhythm (2008) 1.53
Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation: multicenter FIRM registry. J Cardiovasc Electrophysiol (2014) 1.53
The esophageal effects of cryoenergy during cryoablation for atrial fibrillation. Heart Rhythm (2009) 1.52
Percutaneous left atrial appendage closure with an epicardial suture ligation approach: a prospective randomized pre-clinical feasibility study. Heart Rhythm (2009) 1.51
Mode of induction of ventricular tachycardia and prognosis in patients with coronary disease: the Multicenter UnSustained Tachycardia Trial (MUSTT). J Cardiovasc Electrophysiol (2009) 1.51
Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol (2005) 1.50
Variability of coronary venous anatomy in patients undergoing cardiac resynchronization therapy: a high-speed rotational venography study. Heart Rhythm (2007) 1.50
Cardiac sodium channel mutation in atrial fibrillation. Heart Rhythm (2007) 1.50
Catheter ablation of scar-related atypical atrial flutter. Europace (2013) 1.48
Intraprocedural use of ibutilide to organize and guide ablation of complex fractionated atrial electrograms: preliminary assessment of a modified step-wise approach to ablation of persistent atrial fibrillation. J Cardiovasc Electrophysiol (2009) 1.48
Paroxysmal atrioventricular block. Heart Rhythm (2009) 1.48
Echocardiographic measures of acute haemodynamic response after cardiac resynchronization therapy predict long-term clinical outcome. Eur Heart J (2007) 1.48
The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tadalafil on the human QT interval. J Am Coll Cardiol (2005) 1.46
Characterization of the infarct substrate and ventricular tachycardia circuits with noncontact unipolar mapping in a porcine model of myocardial infarction. Heart Rhythm (2006) 1.45
Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol (2005) 1.45
Short-term results of substrate mapping and radiofrequency ablation of ischemic ventricular tachycardia using a saline-irrigated catheter. J Am Coll Cardiol (2003) 1.43
Objective quality assessment of atrial fibrillation ablation: a novel scoring system. Heart Rhythm (2013) 1.43
Multiple ICD discharges associated with lead fracture without triggering of high impedance alert. Pacing Clin Electrophysiol (2009) 1.42
Group beating related T-wave alternans in a patient with atrio-ventricular nodal reentrant tachycardia. Europace (2011) 1.40
Amiodarone is poorly effective for the acute termination of ventricular tachycardia. Ann Emerg Med (2005) 1.40
The impact of respiration on left atrial and pulmonary venous anatomy: implications for image-guided intervention. Heart Rhythm (2005) 1.40
Unpredictable battery depletion of St Jude Atlas II and Atlas+ II HF implantable cardioverter-defibrillators. Heart Rhythm (2011) 1.38
Inducibility of atrial fibrillation with a synchronized external low energy shock post-pulmonary vein isolation predicts recurrent atrial fibrillation. J Cardiovasc Electrophysiol (2008) 1.38
Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. Circulation (2004) 1.37